18F-FDG measures glucose consumption and is an integral part of cancer management.
Most cancer types upregulate their glucose consumption, yielding elevated 18F-FDG PET …

Abstract 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography has become an
important tool for detection, staging and management of many types of cancer. Oncology …

The high rate of glucose uptake to fuel the bioenergetic and anabolic demands of
proliferating cancer cells is well recognized and is exploited with 18F-2-fluoro-2-deoxy-d …

Increased glucose utilization is a hallmark of human cancer that is used to image tumors
clinically. In this widely used application, glucose uptake by tumors is monitored by positron …

Dysregulated cellular metabolism is a characteristic feature of malignancy that has been
exploited for both imaging and targeted therapy. With regard to imaging, deranged glucose …

In contrast to normal cells, cancer cells avidly take up glucose and metabolize it to lactate
even when oxygen is abundant, a phenomenon referred to as the Warburg effect. This …

A high rate of glycolysis, one of the most common features of cancer, is used in positron
emission tomography (PET) imaging to visualize tumor tissues using 18F …

Positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) is a diagnostic
tool to evaluate metabolic activity by measuring accumulation of FDG, an analogue of …

2-Deoxy-2-18F-fluoro-d-glucose (2-FDG) with PET is undeniably useful in the clinic, being
able, among other uses, to monitor change over time using the 2-FDG SUV metric. This …

In the last decade, the possibility to map glucose consumption with 2-[18F] fluoro-2-deoxy-D-
glucose (FDG) imaging profoundly modified the daily activity of most nuclear medicine …